2008-2021年西班牙东南部肌缩侧面硬化症患者的特征,流行病学和与进化和生存相关的因素:基于人口的研究:西班牙东南部肌缩侧面硬化症患者的特征,流行病学和与进化和生存相关的因素,2008-2021年:基于人口的研究
Yaiza García-Ramírez1, Juana-María Cayuela-Fuentes2, María-Pilar Mira-Escolano2
1Teaching Unit of Preventive Medicine and Public Health, Elche, Spain and.
Amyotrophic lateral sclerosis & frontotemporal degeneration
|December 26, 2024
概括
这项研究描述了西班牙的肌缩性侧面硬化症 (ALS) 流行病学,发现黄囊发作,年龄较大,没有瑞卢治疗与生存率较低有关. 这些见解有助于理解ALS的进展和患者的结果.
科学领域:
- 神经学 神经学
- 流行病学 流行病学
- 公共卫生 公共卫生
背景情况:
- 肌缩侧面硬化症 (ALS) 是一种进展性神经退行性疾病,具有重大公共卫生影响.
- 了解ALS的流行病学和预后因素对于改善患者护理和资源配置至关重要.
研究的目的:
- 描述西班牙东南部ALS患者的流行病学,临床特征和生存因素.
- 为了解疾病的演变提供见解,并确定影响生存的因素.
主要方法:
- 在西班牙穆尔西亚地区使用罕见病登记册 (SIER) 的观察性研究 (2008-2021年).
- 计算原始和标准化发病率 (SIR) 和点流行率.
- 卡普兰-梅尔方法和存活分析的日志级别测试.
主要成果:
- 确定了374例ALS病例,全球SIR为1.95/100,000人年,2021年流行率为4.57/100,000点.
- 临床发病后的中位生存时间为2年.
- 与较低的存活率相关的因素包括囊筋发病,发病时的年龄较大以及缺乏riluzole治疗.
结论:
- 这项研究提供了关于西班牙ALS的有价值的流行病学数据,与之前的国际发现保持一致.
- 基于人口的注册表是监测ALS规模和患者结果的有效工具.
相关概念视频
Parkinson's Disease: Overview
476
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
476
Amyloid Fibrils
9.2K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.2K
Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328


